Janet M. Trowbridge

Dermatology

4112 Harbour Pointe Boulevard Southwest
Suite 100
Mukilteo, WA 98275

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: December 08, 2020

Showing 1-1 of 1

Last Updated: 09/26/2026